Furthermore, Bergmann et al. examined the expression of EGFR in human NPTs and found that the expression of EGFR correlated significantly with the grade of malignancy, increasing from low rates of expression in benign tumors and tumors of uncertain behavior to high rates of expression in well- and poorly differentiated endocrine carcinomas [26]. The gene discussed is EGFR; the disease is benign neoplasm.